Mohamed Abdelsalam

6PUBLICATIONS
25CO-AUTHORS
Haematological tumoursBiologically active moleculesMolecular targetsCheminformatics and quantitative structure-activity relationshipsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
Dual FLT3/MAPK14 Proteolysis-Targeting Chimera (PROTAC) Induces Potent Acute Myeloid Leukemia Cell Death.

|Feb 18, 2026
Fragment-Based Design of Pseudo-Natural Products, Synthesis, and Evaluation of Their HIV-1 Latency-Reversing Properties.

Solange A Tanyi, Donatus B Eni, Mohamed Abdelsalam

|Oct 17, 2025
Identification of a Proteolysis-Targeting-Chimera that Addresses Activated Checkpoint Kinase-1 Reveals its Non-Catalytic Functions in Tumor Cells.

Ramy Ashry, Mohamed Abdelsalam, Julia Hausen

|Nov 06, 2023
Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells.

Mohamed Abdelsalam, Mariia Zmyslia, Karin Schmidtkunz

|Apr 23, 2022
Docking, Binding Free Energy Calculations and In Vitro Characterization of Pyrazine Linked 2-Aminobenzamides as Novel Class I Histone Deacetylase (HDAC) Inhibitors.

Emre F Bülbül, Jelena Melesina, Hany S Ibrahim

|Jan 21, 2022
Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis.

Ehab Ghazy, Mohamed Abdelsalam, Dina Robaa

Pageof 1

Frequent Collaborators

6 joint publications

Wolfgang Sippl

3 joint publications

Matthias Schmidt

2 joint publications

Hany S Ibrahim

2 joint publications

Ramy Ashry